Menu
Global B2B sourcing platform
Verified suppliers and manufacturers

Best Selling Reliable Quality Raw Material 99% Powder CAS 302-79-4 Vitamin a Acid/Tretinoin/Retinoic Acid for Skincare

Price $8.50
Min Order 10 grams
Availability In Stock
Shipping From Jiangsu, China
Popularity 414 people viewed
Model NO.:
A-38
Type:
Skin Care
Function:
Acne Treatment
Main Ingredient:
Retinoic Acid
Group:
Female
Certification:
MSDS, Coa
Quality Guarantee Period:
Two Years
Store Method:
Normal Temperature
Cosmetics Approval No.:
-
Sample:
Available
MOQ:
10g
Shelf Life:
2 Years
Test Method:
HPLC
Assay:
99%
Appearance:
Yellow Powder
Package:
PE Bag+Aluminum Foil Bag
Storage:
Cool&Dry Places
CAS No.:
302-79-4
Molecular Formula:
C20h28o2
Molecular Weight:
300.44
Grade:
Cosmetic&Pharmaceutical Grade
Application:
Cosmetic&Pharmaceutical
Brand Name:
Greenway
Certificate:
ISO
Trademark:
Greenway
Transport Package:
1kg/Bag; 25kg/Drum
Specification:
1kg/Bag; 25kg/Drum
Origin:
Jiangsu
HS Code:
2942000000
Product Description

Product NameRetinoic Acid
Other NamesVitamin A Acid/Tretinion/Tretinoin
CAS No.302-79-4
Molecular FormulaC20H28O2
Molecular Weight300.44
AppearanceYellow Powder
Assay99%
GradeCosmetic&Pharmaceutical Grade
Brand NameGreenway

Product Introduction:

Tretinoin is the acid form of vitamin A and is also known as all-trans retinoic acid or ATRA. It is a drug commonly used to treat acne vulgaris and keratosis pilaris. It is available as a cream or gel It is also used to treat acute promyelocytic leukemia. It is also available as a generic.

 

Its success in treating acute promyelocytic leukemia was a major breakthrough in the treatment of this type of leukemia.It works in APL because the majority of cases involve a chromosomal translocation of chromosomes 15 and 17, which causes genetic fusion of the retinoic acid receptor gene to the promyelocytic leukemia  gene.

 

This fusion PML-RAR protein is responsible for preventing immature myeloid cells from differentiating into more mature cells. This block in differentiation is thought to cause leukemia.

 

ATRA acts on PML-RAR to lift this block, causing the immature promyelocytes to differentiate to normal mature blood cells thus decreasing promyelocytes.












  • Similar Products
Full Page Contact Supplier